Livelyhood review: GLP-1 alcohol-craving care, costs and cancellation terms

Identify the care being offered

The Livelyhood homepage presents GLP-1 prescribing for alcohol cravings and describes this use as off-label. The terms identify Livelyhood as a technology platform, with clinical care supplied by independently licensed OpenLoop-affiliated providers. Adults must be in the United States. Availability depends on the service, clinician and pharmacy; signup is supposed to identify unavailable care before charging.

Our reading of those documents is that a prospective patient should ask who will evaluate alcohol use, who follows up and who handles an urgent change. A convenient intake is not enough information to compare the scope of two treatment programs. Ask whether counseling is included, separately billed or referred elsewhere. The terms allow a clinician to decline a prescription or require additional evaluation; paying does not guarantee medication.

Research on a medicine does not validate a particular service

A 2025 randomized trial studied once-weekly injected semaglutide over nine weeks in 48 adults with alcohol use disorder who were not seeking treatment. A 2026 randomized trial studied 108 treatment-seeking participants with alcohol use disorder and obesity over 26 weeks, alongside cognitive behavioral therapy. These are different populations and care settings. Neither study design, by itself, establishes the quality or outcomes of Livelyhood's program.

A useful evidence question for the clinician is whether the proposed medicine, formulation, treatment goal and accompanying support match the cited research. A study of injected semaglutide is not automatic proof for a different drug, a compounded preparation or a service advertised with the word microdose. This is a limitation on what can be inferred from a citation, not a personalized treatment recommendation.

The NIAAA treatment guide describes established alcohol-use treatments, including behavioral care and the approved medications naltrexone, acamprosate and disulfiram. Discuss the available options with a qualified clinician rather than choosing solely from a GLP-1 advertisement. This review does not rank those treatments or provide instructions for changing alcohol use or medication.

Get the complete quote before relying on a monthly headline

The program page displayed a $166-per-month three-month headline and a $199-per-month monthly headline when checked. It also showed additional price figures, first-month discounts and a separate $169 introductory statement. We could not establish one unambiguous payable total from that page. Treat these as observed advertisements, not a verified checkout quote.

Request an itemized amount due today, the billing period, included medication and consultations, the renewal amount and any separately charged services. For a multi-month option, ask whether payment is upfront or collected in installments. A monthly equivalent does not answer that question. Save the actual offer and cancellation terms together so the promised service can be compared with the payment commitment.

Livelyhood's terms say it does not bill insurance. We did not test whether a particular person could obtain reimbursement elsewhere. An advertised payment amount should therefore not be presented as an insured out-of-pocket estimate.

Cancellation and refunds have separate conditions

The refund policy says cancellation can be requested through the account or by email and takes effect at the billing-cycle boundary. It does not promise a prorated refund once the cycle has begun and the associated consultation or medication has been delivered. Medication cannot be returned or refunded after shipment.

The consultation fee is described as fully refundable when the provider finds the person unsuitable and no medication ships. It becomes non-refundable after evaluation and prescription issuance. Those conditions are more specific than a general cancel-anytime message. Before paying, establish the consultation charge and the point at which a shipment is considered processed.

The same policy describes replacement handling for lost or damaged shipments reported within seven days of the expected delivery date. It quotes five to ten business days for an approved refund to reach the original payment method, subject to the bank. That is a published refund timeline, not evidence of how quickly a clinician or support representative replies.

Confirm the medicine, pharmacy and follow-up plan

The terms list partner pharmacies and say the assignment depends on the medicine, location and clinical factors. A list does not identify the pharmacy that will dispense a specific patient's prescription. Ask for the assigned pharmacy, exact formulation, storage instructions and a contact for medication questions before proceeding.

FDA's GLP-1 safety information explains that compounded medicines are not FDA-approved and have not undergone its premarket review for safety, effectiveness and quality. Off-label use and compounding are separate issues: the proposed use concerns the treatment purpose, while compounding concerns the preparation supplied. A clinician should explain both where relevant.

The NIAAA guide supports an assessment of symptoms and treatment needs. Withdrawal can require medical attention. A telehealth subscription should not be assumed to provide emergency or supervised withdrawal care. Ask the clinician which symptoms require urgent help and how care is coordinated if a more intensive service is needed.

Read the privacy notice before sharing health information

The privacy notice describes collection of contact details, health and substance-use histories, payment information and communications. It identifies sharing with clinicians, pharmacies and operational service providers. It also describes access, correction and other patient rights. These are the company's written representations; we did not audit its security controls or handling of patient records.

For an alcohol-use service, privacy questions can be part of comparing care: who can access messages, how records can be transferred to an existing clinician, and where a records or privacy request should go. Review the notice and telehealth consent before providing sensitive information. A discreet-delivery claim alone does not answer those broader questions.

What this review establishes

The public documents establish an identifiable offer and written policies to evaluate. They leave practical questions about the payable plan, assigned pharmacy, counseling provision and follow-up that should be answered for the individual enrollment. Those unanswered questions are not proof that a service is unavailable or poor; they are limits on what this public-source review can verify.

Use our consultation comparison guide to separate medical follow-up from psychotherapy. Compare written answers and total commitments before deciding whether a program addresses the care being sought. No sponsored placement on this page is evidence that another company offers alcohol-use treatment.